Compare Lam Research Corporation (LRCX) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lam Research Corporation vs Sana Biotechnology Inc — how do they compare? Lam Research Corporation trades at $323.01 (market cap $383.63B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Lam Research Corporation is far larger — about 439× Sana Biotechnology Inc's market cap, and Lam Research Corporation pays a 0.34% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| LRCX | SANA | |
|---|---|---|
Market Cap | $383.63B | $873.84M |
Sector | Technology | Health |
52-Week High | $433.33 | $5.92 |
52-Week Low | $94.84 | $2.68 |
Enterprise Value | $382.61B | $848.03M |
Dividend Yield | 0.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
